Fund Holdings — Altium Capital Management LLC

Total Portfolio Value:
$242.11M
Total Bought:
$104.97M
Total Sold:
$85.19M
Net Transaction:
+$19.79M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Vera Therapeutics, Inc.CL A(VERA)710,000714,000+4,000$30.62M$25.83M10.67%-$4.78M
Adma Biologics Inc1,540,0001,510,000-30,000$10.16M$16.88M6.97%+$6.72M
Xenon Pharmaceuticals Inc.(XENE)348,000360,600+12,600$14.98M$14.06M5.81%-$921.6K
Intra-Cellular Therapies Inc113,000193,000+80,000$7.82M$13.22M5.46%+$5.40M
Sarepta Therapeutics, Inc.(SRPT)081,900+81,900$0$12.94M5.34%+$12.94M
Insmed Incorporated(INSM)120,000190,000+70,000$3.26M$12.73M5.26%+$9.47M
Alimera Sciences Inc2,550,0002,150,000-400,000$9.95M$11.95M4.94%+$2.01M
Skye Bioscience, Inc.(SKYE)01,350,093+1,350,093$0$10.81M4.47%+$10.81M
argenx SEADR(ARGX)023,000+23,000$0$9.89M4.09%+$9.89M
Soleno Therapeutics Inc152,909212,909+60,000$6.54M$8.69M3.59%+$2.14M
Avadel Pharmaceuticals Plc0610,000+610,000$0$8.58M3.54%+$8.58M
Catalyst Pharmaceuticals Inc500,000500,0000$7.97M$7.75M3.20%-$225.0K
Contineum Therapeutics, Inc.CL A(CTNM)0429,340+429,340$0$7.56M3.12%+$7.56M
Rezolute, Inc.(RZLT)01,700,000+1,700,000$0$7.31M3.02%+$7.31M
Ascendis Pharma A/SADR(ASND)25,00050,000+25,000$3.78M$6.82M2.82%+$3.04M
Viking Therapeutics, Inc.(VKTX)85,000122,000+37,000$6.97M$6.47M2.67%-$502.8K
Savara Inc.(SVRA)1,335,0001,575,000+240,000$6.65M$6.35M2.62%-$301.1K
Zevra Therapeutics, Inc.(ZVRA)341,4611,162,416+820,955$1.98M$5.70M2.35%+$3.72M
MoonLake ImmunotherapeuticsCL A(MLTX)0115,000+115,000$0$5.06M2.09%+$5.06M
Larimar Therapeutics, Inc.(LRMR)695,000693,000-2,000$5.28M$5.02M2.08%-$250.8K
Xtant Medical Holdings, Inc.(XTNT)7,647,8737,415,413-232,460$8.95M$4.67M1.93%-$4.28M
Axsome Therapeutics, Inc.(AXSM)138,00050,000-88,000$11.01M$4.03M1.66%-$6.99M
The RealReal, Inc.(REAL)800,0001,250,238+450,238$3.13M$3.99M1.65%+$860.3K
Cybin D/B/A Helus Pharma(HELP)13,953,48813,953,4880$5.77M$3.78M1.56%-$1.99M
Outlook Therapeutics, Inc.(OTLK)0501,785+501,785$0$3.70M1.53%+$3.70M
Ultragenyx Pharmaceutical Inc.(RARE)070,000+70,000$0$2.88M1.19%+$2.88M
ORIC Pharmaceuticals, Inc.(ORIC)405,000405,0000$5.57M$2.86M1.18%-$2.71M
Veru Inc.(VERU)2,111,7312,276,692+164,961$1.48M$1.92M0.79%+$437.0K
Perspective Therapeutics, Inc.(CATX)0191,450+191,450$0$1.91M0.79%+$1.91M
Milestone Pharmaceuticals Inc.(MIST)1,212,8821,012,368-200,514$2.17M$1.34M0.55%-$834.7K
Achieve Life Sciences Inc835,470216,310-619,160$3.80M$1.02M0.42%-$2.78M
Allurion Technologies Inc0969,840+969,840$0$967.5K0.40%+$967.5K
BioVie Inc.CL A(BIVI)3,012,6081,982,341-1,030,267$1.59M$793.9K0.33%-$798.5K
Context Therapeutics Inc.(CNTX)0360,001+360,001$0$721.8K0.30%+$721.8K
Karyopharm Therapeutics Inc.(KPTI)740,000740,0000$1.12M$642.0K0.27%-$475.4K
Fat Brands IncW EXP 07 16 202200,000200,0000$974.0K$569.0K0.24%-$405.0K
Aprea Therapeutics, Inc.(APRE)0137,197+137,197$0$558.4K0.23%+$558.4K
Spruce Biosciences Inc1,150,000811,167-338,833$903.8K$419.9K0.17%-$483.8K
Evoke Pharma Inc724,942692,440-32,502$442.2K$366.3K0.15%-$75.9K
Boundless Bio, Inc.(BOLD)200,00083,149-116,851$2.85M$321.8K0.13%-$2.53M
Lexicon Pharmaceuticals, Inc.(LXRX)0121,986+121,986$0$204.9K0.08%+$204.9K
Intelligent Bio Solutions In083,906+83,906$0$161.1K0.07%+$161.1K
Perfect Moment Ltd. Common Stock(PMNT)92,20862,835-29,373$330.1K$135.1K0.06%-$195.0K
Nexgel IncW EXP 12 01 202225,000225,0000$162.0K$98.3K0.04%-$63.7K
Cemtrex Inc0339,961+339,961$0$74.8K0.03%+$74.8K
Wearable Devices LtdW EXP 09 14 2021,411,6001,411,6000$109.5K$70.0K0.03%-$39.5K
Quoin Pharmaceuticals LtdADS66,240103,127+36,887$62.9K$59.8K0.02%-$3.1K
Onfolio Holdings, Inc.W EXP 01 02 202(ONFO)200,000200,0000$8.1K$49.8K0.02%+$41.6K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)731,561731,5610$218.9K$44.4K0.02%-$174.5K
Nexalin Technology IncW EXP 99 99 999105,000105,0000$4.4K$35.7K0.01%+$31.3K
Applied Dna Sciences Inc086,152+86,152$0$35.2K0.01%+$35.2K
VSee Health, Inc.W EXP 99 99 999(VSEE)0150,000+150,000$0$32.5K0.01%+$32.5K
Mobix Labs, Inc.W EXP 99 99 999(MOBX)150,000150,0000$31.5K$26.8K0.01%-$4.7K
Nls Pharmaceutics LtdW EXP 02 02 202200,000200,0000$6.9K$6.9K0.00%+$20
BNB Standard CorporationW EXP 02 11 202(BNC)250,000250,0000$3.3K$3.8K0.00%+$500
Cycurion, Inc.W EXP 99 99 999(CYCU)100,000100,0000$4.3K$3.7K0.00%-$615
Cingulate Inc.W EXP 12 10 202(CING)270,000270,0000$5.7K$2.9K0.00%-$2.8K
Bitcoin Depot IncW EXP 06 30 20250,00050,0000$4.7K$2.4K0.00%-$2.4K
Nexera Technologies LtdW EXP 99 99 999(NEXR)68,68168,6810$4.0K$2.2K0.00%-$1.8K
CDT Equity Inc.W EXP 09 22 202(CDT)100,000100,0000$6.0K$1.6K0.00%-$4.5K
Coliseum Acquisition CorpW EXP 08 22 20228,33328,3330$1.9K$1.4K0.00%-$453
Surrozen, Inc.W EXP 08 01 203(SRZN)82,23382,2330$3.4K$1.4K0.00%-$2.0K
Selina Hospitality PlcW EXP 10 27 202101,439101,4390$710$1.1K0.00%+$391
Tc Biopharm Holdings PlcW EXP 02 10 20218,82318,8230$376$2350.00%-$141
Alpine Immune Sciences Inc77,8480-77,848$3.09M$0—-$3.09M
Aquestive Therapeutics Inc665,0000-665,000$2.83M$0—-$2.83M
Astria Therapeutics Inc142,5320-142,532$2.01M$0—-$2.01M
Avadel Pharmaceuticals PlcADR553,0570-553,057$9.34M$0—-$9.34M
Azitra Inc493,1530-493,153$101.3K$0—-$101.3K
Biohaven Ltd.(BHVN)140,0000-140,000$7.66M$0—-$7.66M
Bruush Oral Care IncW EXP 08 03 20214,4230-14,423$110$0—-$110
Digital Health Acquisition CW EXP 99 99 999150,0000-150,000$19.2K$0—-$19.2K
Gri Bio Inc187,9810-187,981$142.9K$0—-$142.9K
Longboard Pharmaceuticals In170,0000-170,000$3.67M$0—-$3.67M
Marinus Pharmaceuticals Inc176,8400-176,840$1.60M$0—-$1.60M
Mirum Pharmaceuticals, Inc.(MIRM)208,0000-208,000$5.22M$0—-$5.22M
Mobilicom LimitedADS(MOB)135,2920-135,292$161.0K$0—-$161.0K
Neurogene Inc.(NGNE)100,0000-100,000$5.09M$0—-$5.09M
Nocturne Acquisition CorpRIGHT 12 26 2025500,0000-500,000$82.0K$0—-$82.0K
Olema Pharmaceuticals, Inc.(OLMA)605,0000-605,000$6.85M$0—-$6.85M
Perspective Therapeutics, Inc.(CATX)535,6570-535,657$637.4K$0—-$637.4K
Praxis Precision Medicines, Inc.(PRAX)78,1000-78,100$4.77M$0—-$4.77M
Prosomnus IncW EXP 04 20 202150,0000-150,000$3.0K$0—-$3.0K
Relativity Acquisition CorpW EXP 12 15 202100,0000-100,000$0$0—$0
Rhythm Pharmaceuticals, Inc.(RYTM)57,2710-57,271$2.48M$0—-$2.48M
Tourmaline Bio Inc65,4420-65,442$1.50M$0—-$1.50M
Page 1 of 1
Altium Capital Management LLC — 13F Holdings — Q2 2024 | TickerTrail